Notice ID: b75de8a7bda7427aa4921103570153b1Award NoticeAwarded
Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples
Awarded on October 26, 2020. Full description on SAM.gov.
Awarded tounder 75A50121P00003 (source: SAM.gov award notice)• $7.7M
Overview
- Posted
- October 27, 2020
- Notice type
- Award Notice
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Place of performance
- South San Francisco, 94080
- Last updated
- Oct 9, 2026
- Award date
- Oct 26, 2020
- Award amount (SAM.gov award notice)
- $7.7M
Identifiers
- Solicitation number
- 75A50120R00053
- Notice ID
- b75de8a7bda7427aa4921103570153b1
- Award number (PIID)
- 75A50121P00003
Description
The Government issued this award without providing for full and open competition using the authority at FAR 6.302-2 Unusual and Compelling Urgency. A Class Justification and Approval (J&A) was issued on March 21, 2020 for urgent requests for immediate support in response to the expanding outbreak of COVID-19, which was declared on March 11, 2020 and a national emergency via Presidential Proclamation on March 13, 2020. The Class J&A will be posted to the Government Point of Entry (GPE).
Award Overview
Award Number
75A50121P00003
Award Amount (SAM.gov award notice)
$7.7M
Award Date
Oct 26, 2020
Awardee
Awardee UEI
LFM3XDVK31M7
Awardee CAGE Code
3XFL0
Original Solicitation
Notice ID: b75de8a7bda7427aa4921103570153b1
Posted Date: Oct 27, 2020
Original Response Deadline: Not specified
Contacts
Contracting Officer
Primary Contact
Documents
No documents available.
Lifecycle
Solicitation:
75A50120R00053- Awarded
This opportunity has been awarded.
- AwardedOct 27, 2020
Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples
- Sole Source / J&AOct 27, 2020
Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples
- AwardedCurrentOct 27, 2020
Establishment of high throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75A50120R00053
Archive Date
Nov 10, 2020
Office Address
WASHINGTON, DC, 20515